AMWL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
American Well Corp (AMWL) is not a good buy for a beginner investor with a long-term horizon at this time. The stock is facing declining financial performance, negative technical indicators, and reduced analyst price targets. There are no strong positive catalysts or trading signals to justify an immediate investment.
The MACD is negatively expanding, RSI is neutral at 40.428, and moving averages are converging, indicating no clear bullish momentum. The stock is trading near its key support level of 5.406, with resistance at 5.94. Overall, the technical indicators suggest a weak trend.
No significant positive catalysts identified. The reaffirmation of EBITDA guidance for 2026 is mildly encouraging but overshadowed by revenue decline concerns.
Revenue guidance for 2026 is $40M below consensus, reflecting strategic portfolio restructuring and client-specific contract adjustments. Financial performance in Q4 2025 showed significant YoY declines in revenue (-22.11%), net income (-41.57%), and EPS (-45.13%). Analysts have lowered price targets to $5, citing concerns about a 20% revenue decline.
In Q4 2025, revenue dropped to $55.31M (-22.11% YoY), net income fell to -$24.92M (-41.57% YoY), and EPS declined to -1.52 (-45.13% YoY). Gross margin also decreased to 36.06% (-2.96% YoY), indicating worsening profitability.
Analysts from Stifel and TD Cowen have lowered their price targets to $5 and maintained Hold ratings, citing concerns about revenue decline despite a solid Q4 EBITDA beat.
